In vitro activities of linezolid and telithromycin against beta lactam, macrolide, and fluoroquinolone-resistant Streptococcus pneumoniae.

被引：0
|
作者：
Fu, K [1 ]
Johnson, C [1 ]
Herring, S [1 ]
Waites, K [1 ]
机构：
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2001年 / 116卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
11
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [21] Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia
    Kays, MB
    Smith, DW
    Wack, MF
    Denys, GA
    PHARMACOTHERAPY, 2002, 22 (03): : 395 - 399
  • [22] Biological fitness of fluoroquinolone-resistant invasive clinical isolates of Streptococcus pneumoniae
    Duesberg, C. B.
    Nguyen, T. T.
    Welte, T.
    Pletz, M. W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S44 - S44
  • [23] Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams:: SMART program 2001 data
    Hsueh, PR
    Teng, LJ
    Wu, TL
    Yang, D
    Huang, WK
    Shyr, JM
    Chuang, YC
    Wan, JH
    Yan, JJ
    Lu, JJ
    Wu, JJ
    Ko, WC
    Chang, FY
    Yan, YC
    Lau, YJ
    Liu, YC
    Lee, CM
    Leu, HS
    Liu, CY
    Luh, KT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2145 - 2151
  • [24] In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime
    Fuchs, PC
    Barry, AL
    Brown, SD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) : 399 - 401
  • [25] In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities
    Ioannidou, S
    Tassios, PT
    Zachariadou, L
    Salem, Z
    Kanelopoulou, M
    Kanavaki, S
    Chronopoulou, G
    Petropoulou, N
    Foustoukou, M
    Pangalis, A
    Trikka-Graphakos, E
    Papafraggas, E
    Vatopoulos, AC
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 704 - 707
  • [26] Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
    Ferrándiz, MJ
    Fenoll, A
    Liñares, J
    De la Campa, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 840 - 847
  • [27] Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes
    Balsalobre, Luz
    de la Campa, Adela G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 822 - 830
  • [28] Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan
    Yokota, S
    Sato, K
    Kuwahara, O
    Habadera, S
    Tsukamoto, N
    Ohuchi, H
    Akizawa, H
    Himi, T
    Fujii, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) : 3311 - 3315
  • [29] Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants
    Cascone, C
    Mezzatesta, ML
    Santagati, M
    Cafiso, V
    Nicoletti, G
    Stefani, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (05) : 502 - 508
  • [30] Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in a South African child in a tuberculosis treatment facility
    von Gottberg, A
    Ludewick, H
    Bamber, S
    Govind, C
    Sturm, AW
    Klugman, KP
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (11) : 1020 - 1021
12345